Articles

Dasatinib targets chronic myeloid leukemia-CD34+ progenitors as effectively as it targets mature cells

Haematology Division, SA Pathology, SA, Australia;Centre for Cancer Biology, SA, Australia;University of Adelaide, SA, Australia
Haematology Division, SA Pathology, SA, Australia;Centre for Cancer Biology, SA, Australia
Haematology Division, SA Pathology, SA, Australia;Centre for Cancer Biology, SA, Australia
University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, USA
Haematology Division, SA Pathology, SA, Australia;Centre for Cancer Biology, SA, Australia;University of Adelaide, SA, Australia
Haematology Division, SA Pathology, SA, Australia;Centre for Cancer Biology, SA, Australia;University of Adelaide, SA, Australia
Vol. 98 No. 6 (2013): June, 2013 https://doi.org/10.3324/haematol.2012.070268